Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody. . .
Via Krishan Maggon
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
Krishan Maggon 's curator insight,
April 27, 2015 10:21 AM
Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody PreviewView full textDownload full textSupplementalAccess optionsDOI:10.1080/19420862.2015.1032491Sanjaya Singha*, Rachel R. Kroe-Barretta, Keith A. Canadaa, Xiang Zhua, Eliud Sepulvedaa, Helen Wua, Yaqin Hea, Ernest L Raymondb, Jennifer Ahlberga, Lee E. Fregoa, Laura M Amodeoa, Katrina M Catrona, David H. Preskya & Jeffrey H. Hankec Publishing models and article dates explainedReceived: 20 Jan 2015Accepted: 18 Mar 2015
Sign up to comment
Krishan Maggon 's curator insight,
December 31, 2014 3:06 AM
Targeting the IL-17–TH17 pathwayHilary S. Bartlett& Ryan P. MillionAffiliationsCorresponding authorsNature Reviews Drug Discovery 14, 11–12 (2015) doi:10.1038/nrd4518Published online 31 December 2014 |
Krishan Maggon 's curator insight,
March 5, 2015 3:33 AM
Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failedJ. P. Gisbert1,2,*, A. C. Marín1,2, A. G. McNicholl1,2 andM. Chaparro1,2
Article first published online: 4 FEB 2015 DOI: 10.1111/apt.13083 © 2015 John Wiley & Sons Ltd Issue Alimentary Pharmacology & TherapeuticsVolume 41, Issue 7, pages 613–623, April 2015 |